Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 1 | 4 | 5 |
| 1997 | 0 | 6 | 6 |
| 1998 | 1 | 7 | 8 |
| 1999 | 2 | 0 | 2 |
| 2000 | 4 | 7 | 11 |
| 2001 | 1 | 15 | 16 |
| 2002 | 7 | 5 | 12 |
| 2003 | 5 | 8 | 13 |
| 2004 | 8 | 12 | 20 |
| 2005 | 7 | 12 | 19 |
| 2006 | 10 | 13 | 23 |
| 2007 | 13 | 7 | 20 |
| 2008 | 11 | 4 | 15 |
| 2009 | 7 | 10 | 17 |
| 2010 | 17 | 18 | 35 |
| 2011 | 9 | 20 | 29 |
| 2012 | 11 | 5 | 16 |
| 2013 | 14 | 17 | 31 |
| 2014 | 21 | 11 | 32 |
| 2015 | 19 | 19 | 38 |
| 2016 | 12 | 13 | 25 |
| 2017 | 19 | 16 | 35 |
| 2018 | 20 | 21 | 41 |
| 2019 | 20 | 17 | 37 |
| 2020 | 19 | 28 | 47 |
| 2021 | 9 | 39 | 48 |
| 2022 | 6 | 44 | 50 |
| 2023 | 1 | 35 | 36 |
| 2024 | 16 | 18 | 34 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after =2 prior therapies. Blood. 2025 Feb 13; 145(7):708-719.
-
Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):e208-e217.
-
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 Jan 16; 13(1):9.
-
High cellular plasticity state of medulloblastoma local recurrence and distant dissemination. Cell Rep Med. 2025 Jan 21; 6(1):101914.
-
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12; 27(1):89-105.
-
Surgical Margins and Oncologic Outcomes Following Wedge Resection of Pulmonary Metastases in Pediatric and Young Adult Patients with Sarcoma. Ann Surg Oncol. 2025 Apr; 32(4):2883-2890.
-
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Nat Cancer. 2025 Jan; 6(1):123-144.
-
A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer. Gynecol Oncol. 2025 Feb; 193:73-80.
-
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2025 Mar 20; 43(9):1061-1072.
-
The Landmark Series: Neoadjuvant Radiotherapy in Extremity Soft Tissue Sarcoma-The Way to Hypofractionation. Ann Surg Oncol. 2025 Mar; 32(3):1489-1496.